Europe Closed Drug Transfer Systems Market was valued at USD 1.0 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 8.3% from 2024 to 2030.
The European closed drug transfer systems (CSTD) market is experiencing significant growth, driven by increasing awareness of occupational hazards associated with hazardous drug handling and stringent regulatory guidelines. CSTDs are engineered to prevent the escape of hazardous drugs into the environment and protect healthcare workers from potential health hazards. As healthcare facilities continue to prioritize the health and safety of their staff, the demand for CSTDs is expected to grow substantially.
In 2019, the European CSTD market was valued at approximately US$112.01 million and is projected to reach US$487.58 million by 2027, growing at a compound annual growth rate (CAGR) of 20.3%. This surge is attributed to the rising incidence of cancer and the consequent increase in chemotherapy treatments, which necessitate the use of CSTDs to ensure safety during drug preparation and administration.
Several key factors are propelling this market expansion:
Technological Advancements: Innovations in CSTD designs, such as diaphragm-based devices and air cleaning/filtration mechanisms, have enhanced safety and usability, encouraging broader adoption among healthcare facilities.
Regulatory Support: European regulatory bodies have implemented stringent guidelines mandating the use of CSTDs when handling hazardous drugs, further driving market growth.
Healthcare Infrastructure Investment: Increased healthcare expenditure across Europe has led to the modernization of medical facilities, including the integration of advanced safety systems like CSTDs.
The market is segmented based on closing mechanisms, types, technologies, components, and end-users:
Closing Mechanisms: The push-to-turn systems dominated the market in 2019 due to their superior protection and ease of use. Other mechanisms include luer-lock systems, click-to-lock systems, and color-to-color alignment systems.
Types: CSTDs are categorized into membrane-to-membrane systems and needleless systems, with the former holding a larger market share owing to their effectiveness in preventing contamination.
Technologies: The market includes diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices, each offering unique benefits in hazardous drug handling.
Components: Key components comprise vial access devices, syringe safety devices, bag/line access devices, and accessories, all integral to the safe transfer of hazardous drugs.
End-Users: Hospitals and clinics are the primary adopters of CSTDs, followed by oncology centers and other healthcare facilities.
Leading companies operating in the European CSTD market include Becton, Dickinson and Company, ICU Medical, Inc., B. Braun Melsungen AG, Baxter International, Inc., Terumo Corporation, Equashield LLC, Simplivia Healthcare Ltd., CODAN Medizinische Geräte GmbH, Corning Incorporated, and Vygon SAS. These companies are actively engaged in research and development to introduce innovative products that comply with evolving safety standards.
In my personal experience working within the healthcare industry, I've observed a growing emphasis on implementing safety protocols to protect healthcare workers from hazardous drug exposure. The adoption of CSTDs has been a critical component in achieving this goal, providing both safety and confidence to medical professionals during drug preparation and administration.
In conclusion, the European closed drug transfer systems market is on a robust growth trajectory, driven by technological advancements, regulatory mandates, and increased healthcare investments. As the industry continues to prioritize safety and efficiency, the demand for CSTDs is expected to rise, offering lucrative opportunities for market participants.
Get an In-Depth Research Analysis of the Europe Closed Drug Transfer Systems Market Size And Forecast [2025-2032]
BD Medical
Inc
Equashield
LLC
ICU Medical
Inc
Teva Medical Ltd
Corvida Medical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Closed Drug Transfer Systems Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Closed Drug Transfer Systems Market
Needleless Systems
Vial Transfer Systems
Syringe-based Systems
Hospitals
Pharmacies
Homecare Settings
Chemotherapy
Antibiotics
Biologics
Devices
Accessories
Consumables
Plastic
Rubber
Metal
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Closed Drug Transfer Systems Market Research Analysis
1. Introduction of the Europe Closed Drug Transfer Systems Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Closed Drug Transfer Systems Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Closed Drug Transfer Systems Market, By Type
6. Europe Closed Drug Transfer Systems Market, By Application
7. Europe Closed Drug Transfer Systems Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Closed Drug Transfer Systems Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/